Ziadi Hajer, Chougrani Fadela, Cheriguene Abderrahim, Carballeira Leticia, García Vanesa, Mora Azucena
Laboratorio de Referencia de Escherichia coli (LREC), Departamento de Microbioloxía e Parasitoloxía, Universidade de Santiago de Compostela (USC), 27002 Lugo, Spain.
Laboratory of Animal Production Science and Technology, Faculty of Natural and Life Sciences, Abdelhamid Ibn Badis University, Mostaganem 27000, Algeria.
Antibiotics (Basel). 2025 May 9;14(5):485. doi: 10.3390/antibiotics14050485.
High-risk clones, such as sequence type (ST)131 and ST1193, along with multidrug-resistant (MDR) , are globally recognized for their significant role in urinary tract infections (UTIs). This study aimed to provide an overview of the virulence factors, clonal diversity, and antibiotic resistance profiles of extended-spectrum cephalosporin (ESC)- and causing UTIs in humans in the Tebessa region of Algeria.
Forty and 17 isolates exhibiting ESC-resistance were recovered (July 2022-January 2024) from urine samples of patients at three healthcare facilities to be phenotypically and genotypically characterized. Whole genome sequencing (WGS) was performed on the ST1193 clone.
Among isolates, all except one harbored CTX-M-15, with a single isolate carrying . Additionally, two isolates co-harboring and exhibited phenotypic and genotypic hypervirulence traits. Fluoroquinolone resistance (FQR) was detected in 94.1% of isolates. The isolates carried diverse ESC-resistance genes, including CTX-M-15 (87.5%), CTX-M-27 (5%), CTX-M-1, CMY-59, and CMY-166 (2.5% each). Co-carriage of and was identified in three isolates, while 62.5% exhibited FQR. Phylogenetic analysis revealed that 52.5% of belonged to phylogroup B2, including the high-risk clonal complex (CC)131 CH40-30 (17 isolates) and ST1193 (one isolate). In silico analysis of the ST1193 genome determined O75:H5-B2 (CH14-64), and the carriage of IncI1-I(Alpha) and IncF [F-:A1:B10] plasmids. Notably, core genome single-nucleotide polymorphism (SNP) analysis demonstrated high similarity between the Algerian ST1193 isolate and a previously annotated genome from a hospital in Northwest Spain.
This study highlights the spread and genetic diversity of CC131 CH40-30 and hypervirulent clones in Algeria. It represents the first report of a CTX-M-15-carrying ST1193 in the region. The findings emphasize the urgent need for antibiotic optimization programs and enhanced surveillance to curb the dissemination of high-risk clones that pose an increasing public health threat in Algeria. A simplified method based on virulence traits for and is proposed here for antimicrobial resistance (AMR) monitoring.
高风险克隆株,如序列型(ST)131和ST1193,以及多重耐药(MDR)克隆株,因其在尿路感染(UTIs)中的重要作用而在全球范围内得到认可。本研究旨在概述阿尔及利亚泰贝萨地区引起人类UTIs的产超广谱头孢菌素(ESC)大肠埃希菌的毒力因子、克隆多样性和抗生素耐药谱。
(2022年7月至2024年1月)从三个医疗机构患者的尿液样本中分离出40株产ESC耐药大肠埃希菌和17株产ESC耐药肺炎克雷伯菌,进行表型和基因型特征分析。对ST1193克隆株进行全基因组测序(WGS)。
在大肠埃希菌分离株中,除一株外均携带CTX-M-15,一株携带另一种基因。此外,两株同时携带两种基因的大肠埃希菌分离株表现出表型和基因型高毒力特征。94.1%的大肠埃希菌分离株检测到氟喹诺酮耐药(FQR)。大肠埃希菌分离株携带多种ESC耐药基因,包括CTX-M-15(87.5%)、CTX-M-27(5%)、CTX-M-1、CMY-59和CMY-166(各2.5%)。在三株大肠埃希菌分离株中鉴定出两种基因的共同携带情况,62.5%表现出FQR。系统发育分析显示,52.5%的大肠埃希菌属于B2 phylogroup,包括高风险克隆复合体(CC)131 CH40-30(17株)和ST1193(1株)。对ST1193基因组的电子分析确定为O75:H5-B2(CH14-64),并携带IncI1-I(Alpha)和IncF [F-:A1:B10]质粒。值得注意的是,核心基因组单核苷酸多态性(SNP)分析表明,阿尔及利亚的ST1193分离株与西班牙西北部一家医院先前注释的基因组高度相似。
本研究突出了阿尔及利亚CC131 CH40-30和高毒力大肠埃希菌克隆株的传播和遗传多样性。这是该地区携带CTX-M-15的大肠埃希菌ST1193的首次报告。研究结果强调迫切需要抗生素优化计划和加强监测,以遏制在阿尔及利亚对公共卫生构成日益严重威胁的高风险克隆株的传播。本文提出了一种基于毒力特征的简化方法用于大肠埃希菌和肺炎克雷伯菌的抗菌药物耐药性(AMR)监测。